Kolnes, Anders Jensen
Øystese, Kristin Astrid Berland
Sjöstedt, Evelina
Olarescu, Nicoleta Cristina
Heck, Ansgar
Pahnke, Jens
Dahlberg, Daniel
Berg-Johnsen, Jon
Ringstad, Geir
Casar-Borota, Olivera
Bollerslev, Jens
Jørgensen, Anders Palmstrøm
Funding for this research was provided by:
Helse Sør-Øst RHF (HSØ 2020081, 2019054, 2019055, 2022046)
Deutsche Forschungsgemeinschaft (DFG 263024513)
Nasjonalforeningen for Folkehelsen (16154)
Barnekreftforeningen (19008)
EEA Grants/Norway Grants (TAČR TARIMAD TO100078)
Norges forskningsråd (295910 NAPI, 327571 PETABC)
Swedish Cancer Foundation (190157 Fk)
Swedish government and county councils (ALF-agreement)
University of Oslo
University of Oslo
Article History
Accepted: 6 March 2023
First Online: 23 March 2023
Declarations
:
: The study was approved by the Regional Ethics Committee (REK number 2014/1680 approved 23.10.2014) and hospital authority. All patients agreed to participate in the study and provided written informed consent.
: The authors have no relevant financial or non-financial interests to disclose.